PATIENT
INFORMATION LEAFLET
PLEASE READ
THIS LEAFLET CAREFULLY BEFORE USING
FIBROGAMMIN®
P
What does Fibrogammin P contain?
Fibrogammin
P is a freeze-dried powder that contains 250 units of
human plasma coagulation factor XIII.
It also
contains human albumin, glucose and sodium chloride, and
must be dissolved in the Water for Injections supplied
before it is injected.
This
medicinal product contains a maximum of 24 mg glucose
per 250 U vial, which corresponds to a maximum of 360 mg
when the maximum dose of 50U/kg is given to a patient
with 75 kg bodyweight.
This should
be taken into account in patients with diabetes
mellitus.
This
medicinal product contains a maximum of 17 mg sodium per
250 U vial, which corresponds to a maximum of 255 mg
when the maximum dose of 50U/kg is given to a patient
with 75 kg bodyweight.
To be taken
into consideration by patients on a controlled sodium
diet.
The product
is presented in a 6 ml injection vial with one ampoule
of 4 ml water for injections. The ampoule and vial will
appear partly empty but this is normal and does not mean
that there is the wrong amount of powder or solution.
Why have I been prescribed
Fibrogammin P by my doctor?
Fibrogammin
P has been prescribed to stop or prevent bleeding that
you might get because of a lack of factor XIII in your
blood, a condition that you have had from birth.
Fibrogammin P also helps slow healing wounds to heal
more quickly.
Factor XIII
is needed to join together strands of fibrin in the
final stages of blood clotting. This forms a stable
blood clot and hence stops bleeding. If factor XIII is
lacking, a soft clot that is easily dissolved forms and
bleeding can easily re-start or not be stopped as
quickly as normal. This is why the right amount of
factor XIII in the blood is needed to heal wounds and
repair damage to tissues.
Before you take Fibrogammin P.
When
medicines are made from human blood or plasma, certain
measures are put in place to prevent infections being
passed on to patients. These include careful selection
of blood and plasma donors to make sure that those at
risk of carrying infections are excluded, and the
testing of each donation and pools of plasma for signs
of virus/infections. Manufacturers of these products
also include steps in the processing of the blood or
plasma that can inactivate or remove viruses. Despite
these measures, when medicines prepared from human blood
or plasma are administered, the possibility of passing
on infection cannot be totally excluded. This also
applies to any unknown or emerging viruses or other
types of infection.
The measures
taken are considered effective for enveloped viruses
such as human immunodeficiency virus (HIV), hepatitis B
virus and hepatitis C virus, and for the non-enveloped
hepatitis A virus.
The measures
taken may be of limited value against non-enveloped
viruses such as parvovirus B19. Parvovirus B19 infection
may be serious for pregnant women (foetal infection) and
for individuals whose immune system is depressed or who
have some types of anaemia (e.g. sickle cell disease or
haemolytic anaemia).
It is
strongly recommended that every time you receive a dose
of Fibrogammin P, the name and batch number of the
product are recorded in order to maintain a record of
the batches used. Your doctor may recommend that you
consider vaccination against hepatitis A and B if you
regularly receive human plasma-derived products.
When should I not receive
Fibrogammin P?
Do not use
Fibrogammin P if you are allergic to any of the
ingredients. If you are unsure about this then you
should ask your doctor before taking this product.
Usually if you are allergic to Fibrogammin P it will
show up the first time that you use it. Possibly you may
feel sick, dizzy or feel a tightness in your chest, or
you may develop a rash.
What special precautions
should I take?
-
If you experience any of the symptoms of an
allergic reaction to Fibrogammin P stop
injecting the product immediately and call your
doctor.
-
You should visit your doctor regularly to ensure
that your dose is correcting your lack of factor
XIII. He/she may wish to carry out some tests to
make sure that your dose is right.
-
If you are pregnant, planning a family, or
breast-feeding tell your doctor before using
this product. If you have already told your
doctor then follow his/her instructions fully.
-
There is no evidence that Fibrogammin P will
impair your ability to drive or use machines.
-
In cases of recent or current thrombosis (blood
clots in your vessels) you should ask your
doctor for advice.
How much Fibrogammin P should I
use or be given?
Your doctor
will calculate your dose depending on need.
If you are
bleeding it will be about 10 - 20 units (up to a maximum
of 50 units) for every kilogram that you weigh every day
until the bleeding stops.
To prevent
bleeding it will be about 10 units for every kilogram
that you weigh at approximately 4-week intervals.
If you need
an operation, you will need about 35 units for every
kilogram that you weigh before the operation and then as
required until the wound has healed.
Your doctor
will monitor your condition and adjust the dose
according to your needs and any test that may be done.
How is Fibrogammin P
administered?
Fibrogammin
P will normally be given to you by injection into a vein
by your doctor or nurse. The dried powder is completely
dissolved with the diluent supplied, which has been
previously warmed to body temperature. Aseptic
precautions should be taken in dissolving the powder and
drawing up the dose so as not to introduce germs. The
solution is usually very slightly cloudy but should not
contain particles.
Once the
powder is dissolved the solution should be used within 8
hours. If not used immediately after reconstitution it
should be kept in a refrigerator at +2 to + 8 °C for a
maximum of 8 hours.
Fibrogammin
P should be injected or infused slowly. Any solution not
used must be thrown away.
What side effects may I
experience?
In very rare
cases you may experience a rise in your temperature.
This may be a sign that you have suffered an allergic
reaction to Fibrogammin P. Let your doctor know if you
feel uncomfortable during the injection. You may also
experience a rash, hives, difficulty in breathing or a
fall in blood pressure (this may make you feel faint or
dizzy). Your doctor may choose to stop your treatment. A
very small number of patients who are being treated with
Fibrogammin P develop substances in their blood, which
block its effect.
If you
already have a blood clot it may be made more stable and
favour blockage of a blood vessel.
If you
experience a rise in temperature, or if your treatment
becomes less effective, or if you
experience any other undesirable effect tell your doctor
immediately.
What should I do if I miss a
dose when due?
Contact
your doctor or nurse as soon as you remember and
then follow their advice regarding your next
injection.
What happens if I get an
overdose?
No
adverse symptoms of overdosage with Fibrogammin P
are known so far.
How should Fibrogammin P be
stored?
Store in its
outer carton at +2 to +8 °C in a refrigerator. Do not
freeze. When kept in this way Fibrogammin P will keep
until the expiry date shown on the label. Do not use
after this expiry date.
KEEP OUT OF THE REACH AND SIGHT OF
CHILDREN.
Remember this medicine is for you and
only your doctor can prescribe it for you. It should not
be given to others as it may harm them, even if their
symptoms are the same as yours.